Is Compounded Low-dose naltrexone (LDN) Safe and Legal?
Compounded low-dose naltrexone (LDN) is legal when prescribed by a licensed provider. LDN is one of the most commonly compounded medications in the United States.
Get Free Low-dose naltrexone (LDN) Quotes →The Short Answer
Naltrexone is an FDA-approved opioid antagonist used at 50 mg for opioid use disorder. At low doses (typically 0.5–4.5 mg), it appears to modulate the immune system and endorphin pathways and is prescribed off-label for autoimmune conditions, MCAS, fibromyalgia, Crohn's disease, and chronic pain. Because 0.5–4.5 mg doses are not commercially manufactured, LDN must be compounded by a licensed pharmacy.
Who Is Eligible for Compounded Low-dose naltrexone (LDN)?
- A valid prescription from a licensed U.S. healthcare provider is required.
- Commonly prescribed for Hashimoto's, MCAS, fibromyalgia, Crohn's disease, ulcerative colitis, lupus, multiple sclerosis, and chronic pain conditions.
- LDN is off-label for all of these uses — there is no FDA-approved LDN product at these doses.
- Patients should not be taking opioids concurrently (LDN blocks opioid receptors and can precipitate withdrawal).
Safety Considerations
- Starting dose is typically very low (0.5–1.5 mg) and titrated up based on response and tolerability.
- Vivid dreams and sleep disturbances are the most common initial side effects; usually resolve within a few weeks.
- Do not take with any opioid-containing medication, including tramadol or low-dose buprenorphine, without careful provider supervision.
- LDN has a broadly favorable safety profile; serious adverse effects are uncommon at these doses.
Red Flags: What to Avoid
- Sellers offering LDN without a prescription — always illegitimate.
- "Research chemical" naltrexone vendors.
- Pharmacies that will not specify the strength, base, or excipient profile — especially important for MCAS patients who need dye-free and filler-minimized formulations.
Frequently Asked Questions
Is compounded LDN FDA-approved?
No. LDN at 0.5–4.5 mg doses is not FDA-approved for any indication. The 50 mg naltrexone product is FDA-approved for opioid and alcohol use disorder. Compounded LDN is prepared at low doses by licensed pharmacies for patients whose providers have determined the low-dose protocol is appropriate.
Can I get LDN in a liquid or liposomal form?
Yes. Compounding pharmacies routinely prepare LDN as capsules, oral liquid (for precise micro-titration), sublingual drops, topical creams, and nasal sprays. The form chosen depends on your symptoms, starting dose, and tolerance. Liquid forms are particularly useful for very-low-dose starting protocols.
Do I need an MCAS-friendly formulation?
Many MCAS patients do better with capsules that omit common reactive excipients — no dyes, no lactose, no magnesium stearate, specific filler bases. Ask your prescriber and pharmacy about a "dye-free" or "MCAS-friendly" LDN. Compounding Finder lets you note these requirements in your quote request.
Keep Reading
Deep dive: Full article on Low-dose naltrexone (LDN) from our blog →
Pharmacy basics: 503A vs 503B pharmacies — what's the difference? →
Vetting pharmacies: How to find a reputable compounding pharmacy →
Overview: Compounded Low-dose naltrexone (LDN) — overview & pricing →
Compare prices: Compare Low-dose naltrexone (LDN) pricing from licensed pharmacies →
Get Free Low-dose naltrexone (LDN) Quotes
Licensed U.S. compounding pharmacies. No account, no obligation. Results in 1–2 business days.